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ABSTRACT
The ability of 223 Type II restriction endonucle-
ases to hydrolyze RNA–DNA heteroduplex oligo-
nucleotide substrates was assessed. Despite the
significant topological and sequence asymmetry
introduced when one strand of a DNA duplex is
substituted by RNA we find that six restriction
enzymes (AvaII, AvrII, BanI, HaeIII, HinfI and TaqI),
exclusively of the Type IIP class that recognize
palindromic or interrupted-palindromic DNA se-
quences, catalyze robust and specific cleavage of
both RNA and DNA strands of such a substrate.
Time-course analyses indicate that some endo-
nucleases hydrolyze phosphodiester bonds in both
strands simultaneously whereas others appear to
catalyze sequential reactions in which either the
DNA or RNA product accumulates more rapidly.
Such strand-specific variation in cleavage suscepti-
bility is both significant (up to orders of magnitude
difference) and somewhat sequence dependent,
notably in relation to the presence or absence of
uracil residues in the RNA strand. Hybridization to
DNA oligonucleotides that contain endonuclease
recognition sites can be used to achieve targeted
hydrolysis of extended RNA substrates produced
by in vitro transcription. The ability to ‘restrict’ an
RNA–DNA hybrid, albeit with a limited number of
restriction endonucleases, provides a method
whereby individual RNA molecules can be targeted
for site-specific cleavage in vitro.
INTRODUCTION
The discovery of Type II restriction endonucleases
(REases) (1) with their capacity to introduce
sequence-speciﬁc double-strand breaks in complex DNA
molecules (2) and the use of DNA ligase to reconnect such
molecules in predictable and user-deﬁned combinations
(3) provided the key enabling technologies of in vitro
DNA manipulation and the subsequent biotech revolu-
tion. As of June 2010, gene sequences encoding Type II
REases that recognize 313 different target DNA sequences
have been determined and are listed in the restriction
enzyme database (REBASE) (4). Genes encoding different
Type II REases tend to be highly divergent at the level of
primary sequence and, with the exception of
isoschizomers, enzymes that recognize the same sequence
and cleave DNA at identical positions, are not reliably
identiﬁable using standard bioinformatic approaches (5).
As a consequence, restriction enzymes are classiﬁed ac-
cording to combinations of functional properties rather
than on the basis of genetic relatedness (6). X-ray crystal-
lographic analyses, however, reveal underlying structural
relationships that deﬁne, on the basis of conserved active
site architectures, ﬁve distinct groups of Type II REases
(5,7,8). Members of three classes have an absolute require-
ment for divalent cations in order to catalyze DNA
cleavage while the remaining two appear to hydrolyze
their substrates using metal-independent mechanisms (5).
More recently, the available repertoire of REases has
further expanded to include modiﬁed restriction enzymes
with improved cleavage ﬁdelity (Z. Zhu et al., 2009.
United States Patent Application 20090029376) or with
redesigned cleavage-site speciﬁcity (9,10) created through
the successful application of protein engineering
techniques.
With the exception of analyses of theinhibitory effects of
base methylation, by the cognate S-adenosylmethionine-
dependent DNA methyltransferases (MTases) that
protect the host genomes of REase-expressing prokaryotes
in vivo, few published studies have addressed the capacity
of restriction enzymes to cleave chemically modiﬁed
DNA substrates. Those that have are commonly directed
towards answering speciﬁc questions about particular
enzymes, for example, the use of phosphorothioate-
substituted substrates to determine the stereochemistry of
phosphodiester bond hydrolysis (11,12) or assessing the
different effects of various modiﬁed bases and backbone
architectures on the hydrolytic reactions catalyzed by a
pair of neoschizomeric enzymes (13). Notable exceptions
include testing the activity of fourteen different Type II
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within their recognition sites (14) and a systematic in vitro
analysis of the effects of adenine and cytosine methylation
on the activities of a large number of REases [Stickel, S. K.
and Roberts, R. J., unpublished results available in
REBASE (4)]. Such analyses show that some restriction
enzymes are able to cleave atypical DNA substrates
in vitro, including some containing chemical modiﬁcations
that they would not be expected to encounter in vivo. With
this in mind, we considered the possibility that some Type
II REases might catalyze the sequence-speciﬁc hydrolysis
of the other extant biological polynucleotide, RNA.
The only published experimental analysis of REase
activity on RNA–DNA substrates is a very early study
by Molloy and Symons using cDNA–RNA
heteroduplexes produced from SAT RNA and RNA 4
of cucumber mosaic virus (15). Eight enzymes were
identiﬁed that appeared to cleave the DNA strand and,
in the case of HaeIII and TaqI, indirect evidence of
possible RNA strand hydrolysis was presented. Given
the available methods at that time, however, it was not
possible to conﬁrm sequence-speciﬁc cleavage of the RNA
strand or to exclude contaminating ribonuclease activity
as a source of any observed activity (Molloy, P. M. and
Roberts, R. J., unpublished data). Subsequently it was
shown that a single ribonucleotide positioned 30 of the
scissile bond in a DNA duplex blocked cleavage by
EcoRI and BamHI, whereas the latter enzyme was par-
tially active on a duplex containing a ribonucleotide on the
50-side of the target phosphodiester (16,17). During almost
30 years since the Molloy and Symons paper was pub-
lished, there have—to the best of our knowledge—been
no further attempts to identify REases with
ribonucleolytic activity.
From a structural perspective RNA might appear to be
an unlikely surrogate substrate for restriction enzymes, as
the presence of a 20-hydroxyl group adjacent to the scissile
phosphodiester linkage can present a steric barrier to
assembly of a catalytically competent complex with an
enzyme that has evolved to bind and hydrolyze a substrate
that lacks such a group (16). Also, crystallographic
analyses of RNA–RNA homoduplexes and RNA–DNA
heteroduplexes show that the presence of the 20-hydroxyl
group causes both to adopt an A-form helical structure
characterized by an expanded minor groove and con-
tracted major groove relative to canonical B-form DNA
(18,19). As sequence-speciﬁc recognition by Type II
REases commonly involves precise contacts between
amino acid side chains and the edges of nucleotide bases
in the major groove, such interactions are likely to be un-
available, at least in part, to an equivalent RNA substrate
(20) However, structural studies of RNA–DNA
heteroduplexes in solution suggest that the DNA strand
conformation is intermediate between A and B-forms (21)
and crystal structures of Bacillus halodurans RNase H and
human RNase H1 bound to such a heteroduplex show
the RNA and DNA strands adopt A-like and B-like con-
formations, respectively (22,23). Furthermore, A-form
conformational motifs are observed in co-crystal struc-
tures of duplex DNA bound to many DNA-binding
proteins (including homing endonucleases and REases;
24) although others suggest that some such assignations
are predicated on an unduly restrictive deﬁnition of
B-form DNA (25).
Here we report results obtained from activity screening
of a large number of different Type II REases using
ﬂuorophore-tagged RNA–DNA duplex oligonucleotide
substrates. We identify a small subset of restriction
enzymes that catalyze hydrolysis of such substrates and
which may prove useful as sequence-speciﬁc RNA
cleavage reagents.
MATERIALS AND METHODS
All REases and endonuclease reaction buffers, BSA,
Phusion HF DNA polymerase, calf intestinal phosphatase
(CIP), T4 polynucleotide kinase and T4 RNA ligase 2,
were obtained from New England Biolabs (Ipswich,
MA, USA). It should be noted that the TaqI used in
these experiments is the recombinant enzyme, rather
than the native enzyme used by Molloy and Symons,
and differs slightly in amino acid sequence. Synthetic
oligonucleotides and oligoribonucleotides were produced
by the New England Biolabs Organic Synthesis Division
or purchased from Integrated DNA Technologies
(Coralville, IA, USA). Reagents for in vitro transcription
(IVT) using T7 RNA polymerase, RNase-free distilled and
deionized H2O and RNase-free TE buffer were purchased
from Ambion/Applied Biosystems (Austin, TX, USA).
Reagents for polyacrylamide gel electrophoresis of
nucleic acids were obtained from Invitrogen (Carlsbad,
CA, USA).
Initial screening experiments
Unlabeled and 30-FAM- or 50-FAM-tagged synthetic
oligonucleotides or oligoribonucleotides were dissolved
in RNase-free water or TE. Concentrations, normalized
to the theoretical extinction coefﬁcient at 260nm for
each sequence, were determined spectrophotometrically.
Table 1 lists the sequences of oligonucleotides and
oligoribonucleotides used to generate the data presented
in this article and a complete list of oligonucleotides and
oligoribonucleotides used in initial screening experiments
is also provided in Supplementary Table S1. Annealing
reactions (50ml), including 50 pmol of each complemen-
tary strand in NEBuffer 4 (20mM Tris–acetate, pH 7.9,
10mM magnesium acetate, 50mM potassium acetate,
1mM dithiothreitol), were heated at 90 C for 5min and
cooled slowly to room temperature. Endonuclease assays
(20ml) included 1–5 pmol of substrate duplex, with or
without 1–2ml of REase, and were incubated for 3 or 4h
using the NEBuffer (supplemented with 0.1mg/ml BSA
where appropriate) and temperature recommended for
each enzyme. Reaction products were resolved by electro-
phoresis in 20% polyacrylamide/TBE native or 15% poly-
acrylamide/urea/TBE denaturing pre-cast gels (Novex)
and visualized by UV transillumination.
Strand-speciﬁc analysis of cleavage products
Enzymes that showed evidence of heteroduplex cleavage
in the initial screening were reanalyzed using substrates in
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50-ends with FAM or TAMRA ﬂuorophores, respectively.
Oligonucleotides and oligoribonucleotides were dissolved
in RNase-free water at a concentration of 100mM.
Annealing reactions (0.1ml) routinely included 10mlo f
each RNA or DNA strand yielding a nominal duplex con-
centration of 10mM. All restriction assays (0.1ml) used
NEBuffer 4 (supplemented with 0.1mg/ml BSA) and con-
tained 10nM or 20nM (1 or 2pmol) duplex substrate.
Reaction products were mixed with four volumes of
denaturing gel-loading buffer (95% w/v formamide,
25mM EDTA, 0.05% w/v Orange-G dye), heated to
>95 C for 2min and aliquots (20 or 40fmol) were
resolved by electrophoresis in 15% polyacrylamide/urea/
TBE denaturing pre-cast gels (Novex).
FAM (RNA) and TAMRA (DNA) ﬂuorescence
was monitored by gel scanning using a Typhoon 9400
variable mode imager (GE Healthcare, Piscataway, NJ,
USA). Excitation wavelengths of 488nm (with 520nm
BP40 ﬁlter) and 532nm (with 580nm BP30 ﬁlter)
were used for FAM and TAMRA scans, respectively.
Data were collected at 25, 50 or 100mm resolution
with a single scan for each ﬂuorophore using PMT
settings of 300–500V. Scan data were analyzed with
ImageQuant software (GE Healthcare, Piscataway,
NJ, USA).
Both the FAM and TAMRA scans for each gel were
displayed using the high-contrast option in ImageQuant.
When creating dual-color (superimposed) images the
brightness of individual scans was adjusted with
ImageQuant to compensate for the differing ﬂuorescence
yields of the two ﬂuorophores. Images (.bmp ﬁles) were
exported from ImageQuant to Adobe Photoshop for RGB
to CMYK conversion (and cropping) prior to inclusion in
the ﬁgures.
Speciﬁcity of RNA and DNA strand cleavage
Restriction products of DNA–DNA and equivalent
RNA–DNA duplexes were analyzed by
denaturing-PAGE as described. 50-FAM labeled RNA
oligonucleotides corresponding to the predicted products
of cognate RNA cleavage were used as controls. The sizes
of endonuclease cleavage products and control RNAs
(1–10fmol) were also assessed by capillary electrophoresis
using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA).
Relative activity of REases on different substrates
REase speciﬁc activities were determined using highly
concentrated, BSA-free, enzyme stocks. Enzyme
monomer concentration was determined
Table 1. Sequences of oligonucleotides and oligoribonucleotides
Name Sequence
IM 16B 50-AAAGCUAAGCGGACCGAAUCGACUGCAUCGUCAUGAAAAAA-FAM-30
IM 13B 50-TTTTTTCATGACGATGCAGTCGATTCGGTCCGCTTAGCTTT-FAM-30
IM 13C 50-TTTTTTCATGACGATGCAGTCGATTCGGTCCGCTTAGCTTT-30
IM 2B 50-FAM-UUUUUUACUAGUUUAAACCUAGGUACCCCAGGAUACUUUUUU-30
IM 4B 50-FAM-AAAAAAGTATCCTGGGGTACCTAGGTTTAAACTAGTAAAAAA-30
IM 4C 50-AAAAAAGTATCCTGGGGTACCTAGGTTTAAACTAGTAAAAAA-30
IM397D 50-TAMRA-CGAAAATTAATAGGTACCTAGGACCTCGAATCCAGGAAACTATTCACG-30
IM398D 50-TAMRA-CGTGAATAGTTTCCTGGATTCGAGGTCCTAGGTACCTATTAATTTTCG-30
IM399R 50-FAM-CGAAAAUUAAUAGGUACCUAGGACCUCGAAUCCAGGAAACUAUUCACG-30
IM400R 50-FAM-CGUGAAUAGUUUCCUGGAUUCGAGGUCCUAGGUACCUAUUAAUUUUCG-30
IM401R 50-FAM-CGAAAAUUAAUAG-30
IM402R 50-FAM-CGAAAAUUAAUAGGUAC-30
IM403R 50-FAM-CGAAAAUUAAUAGGUACCUAG-30
IM404R 50-FAM-CGAAAAUUAAUAGGUACCUAGGACCU-30
IM405R 50-FAM-CGAAAAUUAAUAGGUACCUAGGACCUCG-30
IM411R 50-FAM-CGUGAAUAGUUUC-30
IM431R 50-FAM-CGAAAAUUAAUAGGUACCUAGGUCCUCGAAUCCAGGAAACUAUUCACG-30
IM432D 50-TAMRA-CGTGAATAGTTTCCTGGATTCGAGGACCTAGGTACCTATTAATTTTCG-30
IM433D 50-GAAATAATACGACTCACTATAGGGGACACCAGAAAATCATTTAAATATTTCAGCATTACCT
-TGGGTTAATTTTGAATCCTTTAATTTAAATGTTGCTAATTGGACCGATTATTTTG-30
IM434D 50-AAACTGCATGATGAACCTGTACTGAGAGCGGCAATAACAGTCGATCCCCTGGTTGCTGATA
-TTTTGCCTAGGTTATAATGGTACCAAAATAATCGGTCCAATTAGCAACATTTAAA-30
IM435D 50-GAAATAATACGACTCACTATAGGGG-30
IM436D 50-AAACTGCATGATGAACCTGTACTGA-30
IM437D 50-TAAATTAAAGGATTCAAAATTAACC-30
IM438D 50-CAAAATAATCGGTCCAATTAGCAAC-30
IM439D 50-AGGTTATAATGGTACCAAAATAATCG-30
IM440D 50-TGATATTTTGCCTAGGTTATAATGGT-30
IM442D 50-GGCAATAACAGTCGATCCCCTGGTTG-30
IM444D 50-GTGTCCCGAAACTATTCACG-30
IM448D 50-FAM-CGTGAATAGTTTCGTTACACCAGAAAATCATTTAAATATTTCAGC-30
IM482D 50-TAMRA-CCAAAATAAAACGTCGACCGGCCAGCTGCGCGAATTCAAATATACCAG-30
IM483D 50-TAMRA-CTGGTATATTTGAATTCGCGCAGCTGGCCGGTCGACGTTTTATTTTGG-30
IM485R 50-FAM-CCAAAAUAAAACGUCGACCGGCCAGCUGCGCGAAUUCAAAUAUACCAG-30
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coefﬁcient at 280nm for each REase. The 2-fold dilution
series of each enzyme were assayed using three different
substrates: bacteriophage   DNA (1mg); TAMRA-labeled
DNA–DNA homoduplex (1 pmol); and TAMRA/
FAM-labeled RNA–DNA heteroduplex (1 pmol). All re-
actions used NEBuffer 4 (supplemented with BSA) and
were incubated for 1 and 3h for DNA–DNA and
RNA–DNA substrates, respectively.  -DNA restriction
products were resolved by agarose gel electrophoresis
whereas ﬂuorescent oligonucleotide and oligoribo-
nucleotide cleavage products were analyzed by
denaturing-PAGE and ﬂuorescence scanning as described
earlier.
Oligonucleotide-directed cleavage of
in vitro-transcribed RNA
Two 116-mer oligonucleotides containing 32-nt self-
complementary 30-termini (IM433D and IM434D, Table
1) were mixed together and extended by Phusion HF poly-
merase in the presence of 0.2mM dNTPs to produce a
200-bp DNA product. An aliquot of this DNA was then
reampliﬁed using 25 cycles of PCR using the same poly-
merase, and 26-mer ﬂanking oligonucleotides, to produce
a template for IVT which contains a T7 promoter
sequence followed by 175bp of DNA that includes
unique AvaII, AvrII, BanI, HinfI and TaqI restriction
sites. IVT employed the T7 Megascript Kit (Ambion,
Austin, TX, USA), using conditions recommended for
the synthesis of short transcripts. Reaction products
were treated with Turbo DNAse (Ambion) to degrade
the template DNA, followed by extraction with phe-
nol:chloroform:isoamyl alcohol (PCI, 25:24:1) and pre-
cipitation with ammonium acetate and isopropanol
followed by centrifugation to recover the RNA. The
IVT product was dissolved in RNAse-free water and
50mg were treated with CIP to remove the 50-triphosphate
groups, followed by a further PCI extraction and precipi-
tation step. Recovered RNA was again dissolved in
RNAse-free water, then 50-monophosphorylated using
T4 polynucleotide kinase. After a third PCI extraction
and precipitation step, the RNA product was dissolved
in 0.1ml RNase-free water and its concentration
determined to be 1.15mM, based on the absorbance at
260nm and a nominal length of 178 ribonucleotides.
The 50-phosphorylated IVT product was coupled to
the 30-hydroxyl group of a 50-FAM-labeled oligoribo-
nucleotide in a ‘splinted’ ligation reaction using a DNA
oligonucleotide and T4 RNA ligase 2 (26). IVT product
(115 pmol), FAM-labeled oligoribonucleotide (460pmol)
and splint DNA oligonucleotide (460pmol) were
combined, heated to >95 C for 2min, then chilled
rapidly in an ice/water bath. T4 RNA ligase 2 buffer
(10 : 0.5M Tris–HCl, pH 7.5, 20mM MgCl2, 10mM
DTT, 17.5ml), ATP (0.1M, 1.0ml) and T4 RNA ligase
2 (100U, 10ml) were added and the reaction
incubated at 37 C for 1h. Ligation reaction products
were extracted with PCI and  70% of the aqueous
phase (corresponding to 80pmol of the original IVT
product) was recovered for precipitation with
ammonium acetate and isopropanol. Precipitated nucleic
acids, comprising RNA ligation products (plus excess
oligonucleotide and oligoribonucleotide) were pelleted
by centrifugation, washed with 70% (w/v) ethanol,
dried using a Speed-Vac centrifuge and redissolved
in 0.1ml RNAse-free water. An aliquot of the original
IVT template PCR product was reampliﬁed with
Phusion HF polymerase using a FAM-labeled oligo-
nucleotide to produce a 50-FAM-tagged DNA duplex
with an identical sequence to the RNA product of the
splinted ligation reaction.
Samples of the FAM-labeled RNA ligation product
(3.2 pmol) were mixed with a 2-fold molar excess of one
of ﬁve different DNA oligonucleotides designed to hybrid-
ize with the RNA at the unique AvaII, AvrII, BanI, HinfI
or TaqI restriction sites. Annealing reactions (20mli n
RNase-free water) were carried out by heating the
RNA/oligonucleotide combinations to 90 C for 2min,
followed by rapid cooling to 4 C using a thermocycler
with a heated lid to minimize evaporation. Restriction
analyses used 5ml of heteroduplex product (0.8 pmol
RNA) in 10ml reactions containing NEBuffer 4 plus 1ml
of the cognate REase and were incubated at 37 (AvaII,
AvrII, BanI, HinfI) or 65 C (TaqI). Equivalent assays
lacking REase were carried out under identical conditions
to monitor non-speciﬁc hydrolysis of the transcript–oligo-
nucleotide duplex. Aliquots of the 50-FAM-labeled DNA
duplex were restricted with the same enzymes to generate
size markers for electrophoretic analyses. Reaction
products were mixed with 40ml of denaturing gel-loading
buffer and resolved by denaturing PAGE as described for
the oligonucleotide heteroduplex cleavage experiments. As
previously, FAM (RNA) ﬂuorescence was monitored by
gel scanning using the Typhoon 9400 variable mode
imager.
RESULTS
Initial screening experiments
A total of 223 REases (and four nicking endonucleases)
were screened for the ability to cleave RNA–DNA
heteroduplex and control substrates as described
above. A complete list of the enzymes tested during this
initial screening process is presented in Supplementary
Table S2. Assays involved extended incubation (3–4h)
using 1–2ml of enzyme which corresponds to 4–100U
depending upon the stock concentration of the individual
REase. These analyses identiﬁed four REases that
appeared to cleave both DNA and RNA strands of
a heteroduplex substrate to some extent (Figure 1).
These enzymes are AvaII (cut site G/GWCC where
W=A or T), AvrII (cut site C/CTAGG), BanI
(cut site G/GYRCC where Y=C or T and R=A or
G) and TaqI (cut site T/CGA). Assays using REase
HinfI (cut site G/ANTC where N=A, C, G or T)
showed limited evidence of RNA strand cleavage but
not of the complementary DNA strand. A sixth REase,
BstNI (cut site CC/WGG where W=A or T), efﬁciently
cleaves only the DNA strand of an RNA–DNA
heteroduplex (Figure 1).
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strands of an RNA–DNA heteroduplex substrate
Oligonucleotide IM398D and the reverse-complementary
oligoribonucleotide IM399R were designed to include re-
striction sites for each of the ﬁve REases identiﬁed in the
initial screening experiments that showed evidence of
RNA-strand hydrolysis (Table 1). As IM398D and
IM399R contain 50-TAMRA and 50-FAM ﬂuorophores,
respectively, a heteroduplex substrate formed from these
two oligomers permits simultaneous monitoring of REase
cleavage of both strands. Figure 2B shows the results of
denaturing-PAGE analysis of the products of assays using
1pmol of IM399R–IM398D substrate and two different
quantities of AvaII, AvrII, BanI and TaqI endonucleases.
Each REase evidently cleaves both substrate strands to
yield deﬁned RNA and DNA fragments. If such
cleavage occurs at the canonical positions within the
target sequence then the predicted sizes of cleavage
products for the DNA strand are 20, 24, 27 and 31
nucleotides for TaqI, AvaII, AvrII and BanI, respectively.
Conversely, those for the RNA strand are 13, 17, 21 and
26 ribonucleotides for BanI, AvrII, AvaII and TaqI, re-
spectively. Inspection of Figure 2B suggests that the
observed electrophoretic mobilities of the different DNA
and RNA fragments appear, to a ﬁrst approximation, to
be consistent with the predicted products of cognate
cleavage.
Increasing the DNA:RNA ratio in substrate annealing
drives RNA-strand cleavage towards completion
For REase-catalysed hydrolysis of RNA–DNA
heteroduplexes to be of any practical utility requires that
the RNA strand cleavage be both speciﬁc and efﬁcient.
REase TaqI cleaves both strands of an RNA–DNA
heteroduplex substrate to completion (Figure 2B, lanes 8
and 9). However, the reactions catalyzed by AvaII, AvrII
and BanI presented in Figure 2B did not result in complete
cleavage of the substrate duplex, a signiﬁcant proportion
13 2 4567 8 9 1 0
AvrII BanI AvaII TaqI U U
11 12 13 14 15 16
I N t s B I f n i H
*R
*D
*R
*D
*R
*D
*R
*D
*R
*D
*R *R
*D
*R
*D
*R
*D
R * R * R * R ** R R * R *
IM 16B 5’-AAAGCUAAGCGGACCGAAUCGACUGCAUCGUCAUGAAAAAA-3’
IM 13B/C 3’-TTTCGATTCGCCTGGCTTAGCTGACGTAGCAGTACTTTTTT-5’
AvaII HinfI TaqI
IM 2B   5’-UUUUUUACUAGUUUAAACCUAGGUACCCCAGGAUACUUUUUU-3’
IM 4B/C 3’-AAAAAATGATCAAATTTGGATCCATGGGGTCCTATGAAAAAA-5’
BstNI BanI AvrII
Figure 1. Initial screening experiments using REases AvaII, AvrII, BanI, BstNI, HinfI and TaqI in assays using RNA-DNA heteroduplex substrates
in which either both DNA and RNA strands or only the RNA strand contain a FAM ﬂuorophore. Sequences of RNA-DNA heteroduplex substrates
with boxes deﬁning REase recognition sites and arrows indicating expected sites of phosphodiester bond cleavage. Electrophoretic analysis of
cleavage products. Lanes 1, 3, 5 and 7: IM 16B RNA-IM 13B DNA heteroduplex substrate (both with 30-FAM label). Lanes 2, 4, 6 and 8: IM
16B RNA-IM 13C DNA heteroduplex substrate (RNA only with 30-FAM label). Lanes 9, 11, 13 and 15: IM 2B RNA-IM 4B DNA heteroduplex
substrate (both with 50-FAM label). Lanes 10, 12, 14 and 16: IM 2B RNA-IM 4C DNA heteroduplex substrate (RNA only with 50-FAM label).
Lanes 1, 2, 9 and 10 show the uncut heteroduplex substrates. Asterisks indicate ﬂuorophore-labelled RNA (*R) and DNA (*D) strands. Expected
sizes of RNA and DNA products are: AvaII (30, 14 nucleotides); HinfI (25, 19 nucleotides); TaqI (22, 21 nucleotides); AvrII (18, 20 nucleotides);
BanI (22, 16 nucleotides); and BstNI (29, 12 nucleotides), respectively. Arrows indicate RNA product of HinfI cleavage. Note that BstNI only
appears to cleave the DNA strand of the RNA-DNA heteroduplex.
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might reﬂect different intrinsic cleavage rates for the
RNA and DNA strands, the presence of insufﬁcient
REase in the assay, an excess of RNA strand in the an-
nealing reaction or a subpopulation of annealed products
that are refractory to cleavage by these enzymes. We
reasoned that the ﬁrst two potential problems might be
addressed by the simple expedient of adding more
REase to the reaction and the latter two by using an
excess of DNA strand in the annealing reaction. To this
end, IM399R and IM398D were annealed at molar ratios
(RNA:DNA) of 1:1 or 0.5:1—the former being equivalent
to the substrate utilized in the earlier assays. Aliquots of
each containing 1 pmol DNA strand were incubated with
REases as previously, except that the number of enzyme
units was increased 2- (AvaII), 3- (AvrII) or 10-fold (BanI)
compared to the highest concentrations used in the prior
experiments. Products of these assays were resolved by
denaturing-PAGE then visualized using the Typhoon
Imager and the results are presented in Figure 2B.
Increasing the enzyme concentration without changing
the RNA:DNA ratio has a signiﬁcant beneﬁcial effect
in the case of BanI (compare lane 4 of Figure 2C with
lane 6 of Figure 2B) but yields only modest improvement
in the capacity of AvaII (lane 2 in Figures 2C and 2B)
and AvrII (Figure 2C, lane 3 and Figure 2B, lane 4) to
cleave the RNA strand. The combination of increased
enzyme concentration and reduced RNA:DNA
ratio, however, results in near-complete cleavage of
the RNA strand by all three enzymes (compare lanes 6,
7 and 8 with lanes 2, 3 and 4 in Figure 2C).
Speciﬁcity of phosphodiester bond cleavage in RNA–DNA
heteroduplex substrates
Oligonucleotide IM397D (Table 1) is a 50-TAMRA-
labeled DNA equivalent of oligoribonucleotide IM399R.
Thus, REase cleavage of an IM397D-IM398D
homoduplex or IM399R–IM398D heteroduplex will
yield identical IM398D-derived products if the same
phosphodiester bonds are hydrolyzed in both substrates.
As no equivalent controls are available for the IM399R-
derived RNA products of heteroduplex cleavage,
50-FAM-labeled oligoribonucleotides IM401R to
IM404R (Table 1) were synthesized based on the predicted
cleavage products of IM399R using REases Ban I, AvrII,
AvaII and TaqI, respectively. The DNA–DNA and
RNA–DNA substrates were each incubated with AvaII,
AvrII, BanI and TaqI REases and the cleavage products
resolved by denaturing-PAGE alongside the relevant syn-
thetic oligoribonucleotide product controls. The scanned
image of this gel is presented in Figure 3A and reveals an
almost exact concordance between the electrophoretic
mobilities of the equivalent DNA products derived from
each substrate and enzyme combination. Similarly the
RNA products of RNA–DNA heteroduplex cleavage by
each enzyme align precisely with the relevant synthetic
RNA controls. Aliquots of all samples shown in
Figure 3A were subsequently resolved at single nucleotide
resolution by capillary electrophoresis. The fragment
analysis data for the AvaII restriction products and syn-
thetic RNA control are shown in Figure 3B and conﬁrm
that the REase cleaves both strands of an RNA–DNA
AvaII TaqI BanI AvrII
13 24 5 6 7 8 9 1 0
B
AvaII BanI AvrII TaqI
U U
13 24 5 6 7 8
C
AvaII
BanI
AvrII
AvaII
BanI
AvrII
UU
5’-FAM-CGAAAAUUAAUAGGUACCUAGGACCUCGAAUCCAGGAAACUAUUCACG-3’
3’-GCTTTTAATTATCCATGGATCCTGGAGCTTAGGTCCTTTGATAAGTGC-TAMRA-5’
A
Figure 2. Cleavage of IM399R–IM398D RNA–DNA heteroduplex substrate by AvaII, AvrII, BanI and TaqI restriction enzymes. (A) Sequence of
IM399R–IM398D heteroduplex substrate with boxes deﬁning REase recognition sites and arrows indicating expected sites of phosphodiester bond
cleavage. (B) Lanes 1 and 10: no enzyme. Lanes 2 and 3: AvaII 100/50U. Lanes 4 and 5: AvrII 40/20U. Lanes 6 and 7: BanI 20/10U. Lanes 8 and 9:
TaqI 40/20U. (C) Additional assays using: different RNA:DNA ratio in substrate annealing reaction. Lanes 1–4: R:D ratio 1:1. Lanes 5–8, R:D ratio
0.5:1. Lanes 1 and 5: no enzyme. Lanes 2 and 6: AvaII 200U. Lanes 3 and 7: AvrII 125U. Lanes 4 and 8: BanI 200U. Green bands, RNA; Red
bands, DNA; Yellow bands, merged RNA and DNA. All assays were incubated for 180min in NEBuffer 4 at 37 C with the exception of TaqI assay
(65 C).
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that are hydrolyzed in an equivalent DNA–DNA
homoduplex creating a 3-base 50 extension. Fragment
analysis data for the AvrII, BanI and TaqI products are
presented in Supplementary Figure S1 and demonstrate
that these enzymes also cleave RNA–DNA and DNA–
DNA substrates at the same phosphodiester bonds.
RNA and DNA strands of heteroduplex substrates may be
cleaved at different rates
Type IIP REases that act on palindromic or interrupted
palindromic, DNA sequences are symmetric homodimeric
enzymes that usually cleave both strands of a DNA duplex
in a concerted fashion with the active site of each
monomer cleaving the scissile bond on a single strand.
REase hydrolysis of an RNA–DNA heteroduplex,
however, might be expected to favor cleavage of one
strand or the other due to the likely structural and
chemical asymmetry of such a substrate. To investigate
this we performed 60min time-course analyses using the
IM399R–IM398D heteroduplex and monitored the accu-
mulation of the individual DNA and RNA products. The
quantity of enzyme used in the assays was kept low to
ensure that the substrate was not completely hydrolyzed
during the period of measurement. Figure 4B shows the
results of such analyses using AvaII (lanes 1–6) and BanI
(lanes 7–12). In the case of AvaII both cleavage products
are observed to accumulate at similar rates. Densitometric
analyses using the unmerged FAM and TAMRA scan
data indicate that 28% of the RNA and 36% of the
DNA strand were hydrolyzed by the 60min time-point
(Figure 4B, lane 6). A very different result was obtained
in the BanI assay where the enzyme exhibits a strong
preference for hydrolysis of the DNA strand. In this
case, 85% of the DNA was converted to product in
60min (Figure 4B, lane 12) compared with only 13%
cleavage of the RNA strand. Figure 4C shows the
results of a similar time course assay using the same
heteroduplex substrate and the REase HinfI. In this
case, only the RNA strand appears to be susceptible to
hydrolysis, with 34% of the substrate cleaved at the 60min
time point (Figure 4C, lane 6). Additional experiments
using higher concentrations of HinfI (500–1500U)
indicate that limited hydrolysis of the DNA occurs but
that cleavage never exceeds 10% of the total DNA
strand in the assay (data not shown). Fragment analysis
data for the HinfI RNA-cleavage product (and control
RNA IM405R) are presented in Supplementary
Figure S1 indicating that the same phosphodiester bond
is hydrolyzed in the equivalent RNA (IM399R) and DNA
(IM397D) strands in RNA–DNA and DNA–DNA duplex
substrates, respectively.
Ribonucleotide substitution at variable positions within
REase target sites can modulate cleavage activity on
heteroduplex substrates
Oligoribonucleotide IM400R is the reverse-
complementary sequence of IM399R (Table 1). An
IM400R–IM397D heteroduplex therefore contains all
the same restriction sites as IM399R–IM398D but with
A
13 24 5 6 7 8 9 1 0 1 1 1 2
AvaII BanI AvrII TaqI
B
AvaII Products
DNA/DNA
RNA/DNA
RNA Std
Figure 3. Speciﬁcity of RNA–DNA heteroduplex cleavage. (A) Lanes
1, 4, 7 and 10: IM397D–IM398D DNA duplex (1pmol) incubated with
10U of AvaII, AvrII, Ban I and TaqI for 60min. Lanes 2, 5, 8 and 11:
IM399R–IM398D RNA–DNA heteroduplex (1pmol) incubated with
AvaII (200U), AvrII (200U), BanI (200U) and TaqI (100U) for
180min. Lanes 3, 6, 9 and 12: synthetic RNA markers (Table 1) cor-
responding to products of cognate RNA cleavage by AvaII (IM403R),
AvrII (IM402R), Ban I (IM401R) and TaqI (IM404R). Green bands,
RNA; red bands, DNA. REase cleavage sites and products are equiva-
lent to those shown in (A). (B) Capillary electrophoretic analysis of
products from Panel A lanes 1–3 (AvaII data). Shaded black peaks:
DNA products. Unﬁlled blue peaks: RNA products. Upper trace:
DNA–DNA duplex products. Middle trace: DNA–RNA heteroduplex
products. Lower trace: synthetic RNA marker. The different peak
heights for RNA and DNA products in the middle trace are a conse-
quence of the higher ﬂuorescent yield of the FAM ﬂuorophore (RNA)
compared to TAMRA (DNA). Equivalent data for the other enzymes
are presented in Supplementary Figure S1.
Nucleic Acids Research, 2010,Vol.38, No. 22 8263the RNA and DNA strands reversed. The former,
however, was observed to be a much poorer AvaII sub-
strate than the latter (data not shown). This could arise as
a consequence of altered topology due to the strand
reversal or because IM400R contains uracil as the W
residue of the AvaII site (G/GWCC) where IM399R has
adenine. To address this, we constructed an IM431R–
IM432D heteroduplex (Table 1) that is identical to
IM399R–IM398D except that the former contains a
rU:dA base pair in the AvaII site where the latter
contains rA:dT. The results of time-course analyses of
AvaII cleavage of both substrates are shown in Figure 5.
As previously, the assay using the IM399R–IM398D sub-
strate (Figure 5, lanes 1–6) shows that the RNA and DNA
products accumulate at a similar rate. However, in the
IM431R–IM432D assay (Figure 5, lanes 7–12) the rate
of hydrolysis of the DNA strand appears to have been
reduced by a factor of  2 and there is little or no
evidence of RNA strand cleavage. Replacement of rA by
rU in the W position of the AvaII site therefore affects
cleavage of both strands of the substrate RNA–DNA
heteroduplex. A similar inhibitory effect upon RNA
strand cleavage is observed with HinfI (G/ANTC) when
the central position contains an rU:dA base pair (data not
shown).
Relative activities of REases on bacteriophage j DNA,
DNA–DNA oligonucleotide duplex and RNA–DNA
heteroduplex substrates
The concentrations of BSA-free REase samples were
determined based on their absorbance at 280nm (triplicate
assays) and the hypothetical extinction coefﬁcients of the
individual enzymes calculated from their amino acid com-
position. Activities were measured on appropriately
diluted REases using bacteriophage   DNA (1mg=0.03
pmol), IM397D–IM398D DNA duplex (1pmol) and
IM399R–IM398D RNA–DNA heteroduplex (1pmol) as
substrates. The 2-fold dilution series of enzymes were used
in end-point assays to identify the lowest concentration of
enzyme that resulted in complete (>95%) cleavage of each
substrate. Reaction products were resolved by agarose gel
electrophoresis in the case of bacteriophage   DNA
and by denaturing-PAGE for oligonucleotide assays.
B AvaII BanI C
13 2 4 5 6 7 8 91 01 11 2 13 24 5 6
HinfI
A
5’-FAM-CGAAAAUUAAUAGGUACCUAGGACCUCGAAUCCAGGAAACUAUUCACG-3’
3’-GCTTTTAATTATCCATGGATCCTGGAGCTTAGGTCCTTTGATAAGTGC-TAMRA-5’
AvaII HinfI BanI
Figure 4. DNA and RNA strands of an RNA–DNA heteroduplex are cleaved at different rates by different restriction enzymes. (A) Sequence of
IM399R–IM398D heteroduplex substrate with boxes deﬁning REase recognition sites and arrows indicating expected sites of phosphodiester bond
cleavage. (B) Time course analyses of IM399R–IM398D heteroduplex (2 pmol) cleavage using 50U AvaII (Lanes 1-6) and 10U BanI (lanes 7–12).
Time points are: lanes 1 and 7, 10min. Lanes 2 and 8, 20min. Lanes 3 and 9, 30min. Lanes 4 and 10, 40min. Lanes 5 and 11, 50min. Lanes 6 and
12, 60min. (C) Time course analysis of IM399R–IM398D heteroduplex cleavage (2 pmol) using 20U HinfI. Time points are: 10min, 20min, 30min,
40min, 50min and 60min for lanes 1–6.
13 2 4567891 0 1 1 1 2
AvaII Assays
5’-r(GGACC)-3’
3’-d(CCTGG)-5’
5’-r(GGUCC)-3’
3’-d(CCAGG)-5’
Figure 5. Replacing rA with rU in the recognition site impairs hydroly-
sis of an RNA–DNA heteroduplex substrate by AvaII. Time course
analysis of IM399R–IM398D heteroduplex (2pmol, lanes 1–6) and
IM432R–IM431D heteroduplex (2pmol, lanes 7–12) cleavage by 50
U AvaII. Time points are: lanes 1 and 7, 10min. Lanes 2 and 8,
20min. Lanes 3 and 9, 30min. Lanes 4 and 10, 40min. Lanes 5 and
11, 50min. Lanes 6 and 12, 60min. Note that these heteroduplexes are
identical except that the IM399R–IM398D substrate contains a central
rA:dT base pair in the AvaII site that is replaced by rU:dA in the
IM432R–IM431D substrate.
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Supplementary Figure S2 and the calculated activities of
each REase are presented in Table 2. The activities of
AvaII, AvrII, BanI, HinfI and TaqI (in pmol sites
cleaved per   unit) are essentially equivalent on both
DNA substrates, varying by less than 3-fold between
assays using   DNA and the IM97D–IM398D oligo-
nucleotide duplex.
AvaII, BanI, HinfI and TaqI REases each hydrolyze an
RNA–DNA heteroduplex at least two orders of magni-
tude less efﬁciently than the equivalent DNA–DNA
homoduplex. AvrII is much less active on duplex DNA
than the other REases tested, hydrolyzing around
100fmol of sites per   unit compared to 1.6–3.2pmol
per unit for AvaII, BanI, HinfI and TaqI. However,
unlike the other REases, AvrII cleaves homoduplex and
heteroduplex substrates at near-equivalent rates, 0.1 and
0.033 pmol sites cleaved per   unit, respectively (Table 2).
Oligonucleotide-directed ‘restriction’ of long RNA
molecules
Oligonucleotides IM433D–IM436D (Table 1) were used
to construct an IVT template wherein a T7 promoter
sequence was appended to a 175-bp DNA sequence–
derived from part of the catIII antibiotic resistance gene
(27)–that was modiﬁed to introduce unique restriction
sites for AvaII, AvrII, BanI, HinfI and TaqI REases. An
IVT product was synthesized from this template, treated
with alkaline phosphatase to remove the 50-triphospate
group, 50-phosphorylated with T4 polynucleotide kinase
and attached to a FAM-labeled oligoribonucleotide
(IM411R, Table 1) in a splinted ligation reaction using a
DNA oligonucleotide (IM444D, Table 1) and T4 RNA
Ligase 2 as described in the ‘Materials and Methods’
section. This yielded a population of RNA molecules,
 191-nt long, each containing a ﬂuorescent reporter
group at the 50-end (Figure 6A). A duplex DNA substrate
of identical sequence carrying a 50-FAM-group was con-
structed via PCR ampliﬁcation of the original IVT
template PCR using oligonucleotides IM436 and IM448
(Table 1).
Oligonucleotides IM437D-IM440D and IM442D
(Table 1) were designed to hybridize to the FAM-tagged
RNA, in ﬁve separate annealing reactions, at positions
that included the restriction sites for HinfI, AvaII, BanI,
AvrII and TaqI REases, respectively. Restriction assays
HinfI AvaII BanI AvrII TaqI
M M - + - + - + - + - +
B
3 12 456789 1 0 1 1 1 2
A
5’--FAM--cgugaauaguucGGGACACCAGAAAA
UCAUUUAAAUAUUUCAGCAUUACCUUGGGUUAAUU
UUGAAUCCUUUAAUUUAAAUGUUGCUAAUUGGACC
GAUUAUUUUGGUACCAUUAUAACCUAGGCAAAAUA
UCAGCAACCAGGGGAUCGACUGUUAUUGCCGCUCU
CAGUACAGGUUCAUCAUGCAGUUU-3’
I I a v A I f n i H
BanI AvrII
TaqI
Figure 6. Oligonucleotide-directed hydrolysis of in vitro transcribed
RNA by restriction endonucleases. (A) Predicted sequence of
FAM-tagged RNA created by ligation of oligoribonucleotide IM411R
(lower case script) to IVT product that initiated at nucleotide G23 of
the template DNA (upper case script). Unique HinfI, AvaII, BanI,
HinfI and TaqI restriction sites are shown with arrows indicating
expected sites of phosphodiester bond cleavage. (B) Speciﬁc cleavage
of FAM-tagged RNA. Oligonucleotides IM437D, IM438D, IM439D,
IM440D and IM442D were hybridized with the FAM-tagged RNA to
produce ﬁve different heteroduplex substrates that include restriction
sites for the HinfI, AvaI, BanI, AvrII and TaqI REases, respectively.
All ﬁve substrates were incubated in the absence ( ) and presence (+)
of the cognate REase. Assays using HinfI (50U), AvaII (500 U), BanI
(160U) and AvrII (10U) were incubated for 60min at 37 C. The TaqI
assay (50U) was incubated at 65 C for 60min. Approximately 250fmol
of RNA were loaded in each gel lane. Size standards (M) were
produced by restriction of a FAM-labeled DNA duplex with
the same sequence as the RNA substrate and using the equivalent
REases.
Table 2. Relative activities of restriction endonucleases on DNA–DNA and RNA–DNA substrates
Endonuclease AvaII AvrII BanI HinfI TaqI
Speciﬁc Activity (units per mg) (mg   DNA cleaved per hour per mg) 2.6 10
6 1.9 10
5 5.3 10
6 3.7 10
5 2.5 10
6
Cleavage sites in   DNA 35 2 25 148 121
pmol   sites cleaved (per unit)
a 1.05 0.06 0.75 4.44 3.63
pmol DNA-DNA oligo sites cleaved (per unit) 1.6 0.1 1.6 1.6 3.2
pmol RNA-DNA oligo sites cleaved (per unit) 0.0067 0.033 0.0042
b 0.0036
c 0.033
Ratio D-D:R-D cleavage 240 3 381
b 444
c 97
a1mg   DNA=0.03 pmol.
bBased on RNA strand data (DNA strand of heteroduplex is cut at least an order of magnitude more rapidly).
cBased on RNA strand data (No cleavage of DNA strand of heteroduplex was observed).
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substrates where the annealed oligonucleotide spanned the
cognate REase cleavage site. As previously, reaction
products were resolved by denaturing polyacrylamide gel
electrophoresis and FAM ﬂuorescence was monitored
using the Typhoon imager. Electrophoretic size standards
were generated by cleavage of the 50-FAM-labeled DNA
duplex substrate with each of the ﬁve enzymes and mixing
of the reaction products following dilution in denaturing
loading buffer. Figure 6B shows the result of such an
analysis and indicates that each REase cleaves the
heteroduplex at a single site and that such cleavage does
not occur in the absence of added endonuclease. The
observed electrophoretic mobility of each restriction
product is consistent with the expected sizes resulting
from cleavage of the 191nt RNA with HinfI (66nt),
AvaII (93nt), BanI (105nt), AvrII (120nt) and TaqI
(148nt). In addition, the electrophoretic mobilities
of the RNA cleavage products (Figure 6B, lanes 3, 5, 7,
9 and 11) appear to be essentially identical to those of
the equivalent duplex DNA markers produced by restric-
tion with the same enzymes (Figure 6B, lanes 1 and 12).
Although slight size variation is observed for the restricted
RNA products in each case, inspection of the equivalent
uncut RNA samples suggests that this is a consequence
of heterogeneity among the products of the IVT
and/or splinted-ligation reactions rather than relaxed spe-
ciﬁcity of the relevant REases. We therefore conclude
that these restriction enzymes are able to catalyze
the site-speciﬁc hydrolysis of long-RNA molecules
when directed to do so by hybridization of a short DNA
oligonucleotide to the cognate cleavage site within
the RNA.
Retesting enzymes used by Molloy and Symons
Molloy and Symons reported that eight REases (AluI,
EcoRI, HaeIII, HhaI, HindII, MspI, SalI and TaqI)
could cleave one or both strands of an RNA–DNA
heteroduplex substrate containing the relevant recognition
sequences (15), whereas we only identiﬁed TaqI as having
such activity in our experiments. We therefore retested
each of these REases using IM482D–IM483D
homoduplex and IM485R–IM483D heteroduplex sub-
strates containing a single recognition site for each
enzyme. Three hour assays using 100 U of each REase
(Supplementary Figure S3) again conﬁrms DNA and
RNA-strand hydrolysis by TaqI (lane 18) and also
reveals heteroduplex cleavage–of the RNA strand only–
by HaeIII (lane 8).
DISCUSSION
By screening >200 different Type II REases we identiﬁed
six enzymes that are able to cleave the RNA strand of an
RNA–DNA heteroduplex substrate, in the form of syn-
thetic oligonucleotide/oligoribonucleotide duplexes or via
hybridization of DNA oligonucleotides to the relevant
cognate sequences in longer RNA molecules prepared by
IVT. Four of these hydrolyze both the RNA and DNA
strands but, surprisingly, one of them (HinfI) only cuts the
RNA strand well. The activities of HaeIII and TaqI on
RNA–DNA hybrid substrates, described by Molloy and
Symons in 1980 (15), are conﬁrmed in the present study,
but we could ﬁnd no evidence of such activity for six add-
itional candidate REases identiﬁed in their article.
However, it is possible, even likely, that additional
enzymes having low levels of such activity were missed
during our initial screening experiments. Similarly, as
these experiments all used reaction conditions optimized
for cleavage of DNA by the different REases they might
fail to detect an enzyme that was able to hydrolyze an
RNA–DNA heteroduplex if assayed at a different pH or
in the presence of different salts or divalent cations. In
addition, it is well established that some REases require
that two copies of their recognition sequence be bound
simultaneously for them to become competent in catalysis
(28). Clearly, such an enzyme would not be detectable
using our screening system in the event that such
binding were required to occur in cis. Despite such
caveats, it seems that the capacity to hydrolyze RNA–
DNA hybrids is the exception rather than the rule
among Type II REases.
All the enzymes shown to cut the RNA strand of a
heteroduplex substrate are members of the Type IIP
subclass of REases, homodimeric enzymes that bind to,
and cleave within, palindromic (AvrII, BanI, HaeIII and
TaqI) or interrupted palindromic (AvaII, BanI and HinfI)
DNA sequences, with each monomer catalyzing the con-
certed hydrolysis of one of the two DNA strands (6). With
the exception of HaeIII, which has not been assigned to
any of the ﬁve REase structural superfamilies, all these
enzymes are members of the structural class that employ
a canonical PD-(E/D)XK catalytic motif to achieve
phosphodiester bond hydrolysis (5). In addition, ﬁve of
the enzymes cleave the DNA duplex to generate hydrolysis
products with a 50-extension of 2 (TaqI), 3 (AvaII and
HinfI) or 4 (AvrII and BanI) nt. However, the presence
of the 50-extensions and their lengths are likely less signiﬁ-
cant than the observation that this positional speciﬁcity is
absolutely maintained when the substrate is not DNA but
an RNA–DNA heteroduplex. This demonstrates that any
structural changes that occur when one substrate DNA
strand is replaced by RNA, for example transitioning to
a more A-like conformation, are readily accommodated
by the active sites of these REases. An intriguing possibil-
ity, that we hope to address by X-ray crystallographic
studies, is that the enzymes that hydrolyze RNA–DNA
heteroduplexes have evolved active site architectures that
preferentially bind A-form DNA or induce structural
transitions towards A-like conformations on DNA
binding.
In addition to the likely role of topological differences
in modulating cleavage rates for DNA–DNA and RNA–
DNA substrates we also ﬁnd evidence of sequence
speciﬁc-effects. Most notably, while AvaII (recognition
sequence C/CWGG where W=A or T) cleaves both
strands of an RNA–DNA heteroduplex at more or less
equivalent rates when the central base pair is rA:dT, hy-
drolysis of an otherwise identical substrate containing an
rU:dA base pair is slightly impaired in DNA strand hy-
drolysis and cleavage of the RNA strand is no longer
8266 Nucleic Acids Research, 2010,Vol.38, No. 22observed. As Ehrlich and co-workers have previously
shown that AvaII efﬁciently cleaves Bacillus subtilis
PBS1 bacteriophage DNA in which 98% of dT nucleo-
tides are replaced by dU (29) it appears that the impair-
ment we observe must arise from a combination of
topological and base-speciﬁc effects. The same authors
also show that PBSI DNA is restricted efﬁciently by
TaqI (T/CGA) but that HinfI activity (G/ANTC) is sig-
niﬁcantly impaired when the dT residue in the fourth
position on both strands is replaced by dU.
AvaII, BanI, HinfI and TaqI REases all restrict
the RNA-strand of an RNA–DNA heteroduplex substrate
at least two orders of magnitude less efﬁciently than
the equivalent DNA–DNA homoduplex. In other
respects, however, the properties of the different REases
are quite distinct. AvaII and TaqI hydrolyze both strands
of the IM399R–IM398D heteroduplex substrate at
equivalent rates in what appears to be a concerted
reaction similar to that expected for a Type IIP enzyme
cleaving duplex DNA. The other two enzymes reveal
strong and opposing, strand-speciﬁc biases, BanI prefer-
entially hydrolyzing the DNA and HinfI favoring cleavage
of the RNA strand, respectively. At present, we do not
know what is responsible for the slow rate of heteroduplex
cleavage by these enzymes. Nor do we know how
AvrII REase is almost equally effective at cleaving sites
in DNA and DNA–RNA hybrid substrates. Future
studies, including structural and mechanistic analyses,
will no doubt provide a deeper understanding of the
properties of these unusually promiscuous restriction
enzymes.
The capacity to cleave speciﬁc RNA phosphodiester
bonds using REases has potential applications in molecu-
lar biology. The 30- and 50-ends of RNA molecules—
whether isolated from cells or synthesized by IVT—often
show slight heterogeneity in length. The latter also contain
modiﬁed 50-termini, in the form of 50-triphosphate and the
7-methylguanosine ‘cap’ in prokaryotes and eukaryotes,
respectively. Although such RNAs can be ‘trimmed’
using ribozymes or DNAzymes to eliminate 30-end hetero-
geneity (30), oligonucleotide-directed restriction can, in
principle, be used to produce homogeneous RNAs with
uniform 50 and 30 RNA termini. This is particularly ap-
plicable to RNAs produced by IVT where the relevant
REase recognition sequences are readily introduced to
the template DNA using PCR. A second possible applica-
tion is in the construction of chimeric polynucleotides
from multiple RNA (or RNA and DNA) molecules. As
the REases cleave the RNA strand of an RNA–DNA
heteroduplex at a speciﬁc phosphodiester bond it is rela-
tively easy to construct such chimeras via splinted ligation
reactions using T4 RNA ligase 2 (31). Oligonucleotide-
directed RNA cleavage could also be exploited as a diag-
nostic tool for the identiﬁcation of a particular RNA
transcript (or viral RNA) within a complex RNA
sample provided that the sequence of the target RNA is
known and contains the relevant REase recognition sites.
In principle, this could be combined with electrophoretic
separation of the cleavage products to generate an RNA
proﬁle for an RNA virus or to identify alternatively
spliced variants of eukaryotic mRNAs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors thank Beth Ann Cantin and Laurie Mazzola
for capillary electrophoretic analysis, Joe Cummings, John
Greci, Diana O’Loane, Terry Petronzio and Suzanne
Sweeney for providing concentrated restriction enzyme
samples, Dave Landry and Katherine Marks for advice
regarding ﬂuorescence detection of polynucleotides, and
three anonymous Referees for suggested enhancements
of the article.
FUNDING
Funding for open access charge: New England Biolabs,
Inc.
Conﬂict of interest statement. None declared.
REFERENCES
1. Smith,H.O. and Wilcox,K.W. (1970) A restriction enzyme from
Hemophilus inﬂuenzae. I. Puriﬁcation and general properties.
J. Mol. Biol., 51, 379–391.
2. Danna,K. and Nathans,D. (1971) Speciﬁc cleavage of simian
virus 40 DNA by restriction endonuclease of Hemophilus
inﬂuenzae. Proc. Natl Acad. Sci. USA, 68, 2913–2917.
3. Cohen,S.N., Chang,A.C., Boyer,H.W. and Helling,R.B. (1973)
Construction of biologically functional bacterial plasmids in vitro.
Proc. Natl Acad. Sci. USA, 70, 3240–3244.
4. Roberts,R.J., Vincze,T., Posfai,J. and Macelis,D. (2010)
REBASE–a database for DNA restriction and modiﬁcation:
enzymes, genes and genomes. Nucleic Acids Res., 38, D234–D236.
5. Orlowski,J. and Bujnicki,J.M. (2008) Structural and evolutionary
classiﬁcation of Type II restriction enzymes based on
theoretical and experimental analyses. Nucleic Acids Res., 36,
3552–3569.
6. Roberts,R.J., Belfort,M., Bestor,T., Bhagwat,A.S., Bickle,T.A.,
Bitinaite,J., Blumenthal,R.M., Degtyarev,S., Dryden,D.T.,
Dybvig,K. et al. (2003) A nomenclature for restriction enzymes,
DNA methyltransferases, homing endonucleases and their genes.
Nucleic Acids Res., 31, 1805–1812.
7. Sokolowska,M., Czapinska,H. and Bochtler,M. (2009) Crystal
structure of the beta beta alpha-Me type II restriction
endonuclease Hpy99I with target DNA. Nucleic Acids Res., 37,
3799–3810.
8. Galburt,E.A. and Stoddard,B.L. (2002) Catalytic mechanisms of
restriction and homing endonucleases. Biochemistry, 41,
13851–13860.
9. Rimseliene,R., Maneliene,Z., Lubys,A. and Janulaitis,A. (2003)
Engineering of restriction endonucleases: using methylation
activity of the bifunctional endonuclease Eco57I to select the
mutant with a novel sequence speciﬁcity. J. Mol. Biol., 327,
383–391.
10. Morgan,R.D. and Luyten,Y.A. (2009) Rational engineering of
type II restriction endonuclease DNA binding and cleavage
speciﬁcity. Nucleic Acids Res., 37, 5222–5233.
11. Connolly,B.A., Eckstein,F. and Pingoud,A. (1984) The
stereochemical course of the restriction endonuclease
EcoRI-catalyzed reaction. J. Biol. Chem., 259, 10760–10763.
12. Mizuuchi,K., Nobbs,T.J., Halford,S.E., Adzuma,K. and Qin,J.
(1999) A new method for determining the stereochemistry of
DNA cleavage reactions: application to the SﬁI and HpaII
restriction endonucleases and to the MuA transposase.
Biochemistry, 38, 4640–4648.
Nucleic Acids Research, 2010,Vol.38, No. 22 826713. Gromova,E.S., Kubareva,E.A., Vinogradova,M.N., Oretskaya,T.S.
and Shabarova,Z.A. (1991) Peculiarities of recognition of
CCA/TGG sequences in DNA by restriction endonucleases MvaI
and EcoRII. J. Mol. Recognit., 4, 133–141.
14. Langhans,M.T. and Palladino,M.J. (2009) Cleavage of mispaired
heteroduplex DNA substrates by numerous restriction enzymes.
Curr. Issues Mol. Biol., 11, 1–12.
15. Molloy,P.L. and Symons,R.H. (1980) Cleavage of DNA.RNA
hybrids by type II restriction enzymes. Nucleic Acids Res., 8,
2939–2946.
16. Ohtsuka,E., Ishino,Y., Ibaraki,K. and Ikehara,M. (1984)
Recognition by restriction endonuclease EcoRI of
deoxyoctanucleotides containing modiﬁed sugar moieties.
Eur. J. Biochem., 139, 447–450.
17. Nazarenko,I.A., Gorbunov Iu,A. and Malygin,E.G. (1987)
[Cleavage of synthetic RNA-DNA hybrids with restriction
endonucleases BamH1 and Sau3A]. Bioorg. Khim., 13, 928–933.
18. Dock-Bregeon,A.C., Chevrier,B., Podjarny,A., Moras,D.,
deBear,J.S., Gough,G.R., Gilham,P.T. and Johnson,J.E. (1988)
High resolution structure of the RNA duplex [U(U-A)6A]2.
Nature, 335, 375–378.
19. Egli,M., Usman,N. and Rich,A. (1993) Conformational inﬂuence
of the ribose 20-hydroxyl group: crystal structures of DNA-RNA
chimeric duplexes. Biochemistry, 32, 3221–3237.
20. Pingoud,A. and Jeltsch,A. (2001) Structure and function of type
II restriction endonucleases. Nucleic Acids Res., 29, 3705–3727.
21. Salazar,M., Fedoroff,O.Y., Miller,J.M., Ribeiro,N.S. and
Reid,B.R. (1993) The DNA strand in DNA.RNA hybrid duplexes
is neither B-form nor A-form in solution. Biochemistry, 32,
4207–4215.
22. Nowotny,M., Gaidamakov,S.A., Crouch,R.J. and Yang,W. (2005)
Crystal structures of RNase H bound to an RNA/DNA hybrid:
substrate speciﬁcity and metal-dependent catalysis. Cell, 121,
1005–1016.
23. Nowotny,M., Gaidamakov,S.A., Ghirlando,R., Cerritelli,S.M.,
Crouch,R.J. and Yang,W. (2007) Structure of human RNase H1
complexed with an RNA/DNA hybrid: insight into HIV reverse
transcription. Mol. Cell, 28, 264–276.
24. Lu,X.J., Shakked,Z. and Olson,W.K. (2000) A-form
conformational motifs in ligand-bound DNA structures.
J. Mol. Biol., 300, 819–840.
25. Marathe,A., Karandur,D. and Bansal,M. (2009) Small local
variations in B-form DNA lead to a large variety of global
geometries which can accommodate most DNA-binding protein
motifs. BMC Struct. Biol., 9, 24.
26. Nandakumar,J., Ho,C.K., Lima,C.D. and Shuman,S. (2004) RNA
substrate speciﬁcity and structure-guided mutational analysis of
bacteriophage T4 RNA ligase 2. J. Biol. Chem., 279,
31337–31347.
27. Murray,I.A., Hawkins,A.R., Keyte,J.W. and Shaw,W.V. (1988)
Nucleotide sequence analysis and overexpression of the gene
encoding a type III chloramphenicol acetyltransferase.
Biochem. J., 252, 173–179.
28. Bath,A.J., Milsom,S.E., Gormley,N.A. and Halford,S.E. (2002)
Many type IIs restriction endonucleases interact with two
recognition sites before cleaving DNA. J. Biol. Chem., 277,
4024–4033.
29. Huang,L.H., Farnet,C.M., Ehrlich,K.C. and Ehrlich,M. (1982)
Digestion of highly modiﬁed bacteriophage DNA by restriction
endonucleases. Nucleic Acids Res., 10, 1579–1591.
30. Coleman,T.M., Wang,G. and Huang,F. (2004) Superior 50
homogeneity of RNA from ATP-initiated transcription under the
T7 phi 2.5 promoter. Nucleic Acids Res., 32, e14.
31. Bullard,D.R. and Bowater,R.P. (2006) Direct comparison of
nick-joining activity of the nucleic acid ligases from bacteriophage
T4. Biochem. J., 398, 135–144.
8268 Nucleic Acids Research, 2010,Vol.38, No. 22